BlackRock »

Quince Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of Quince Therapeutics shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Quince Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Quince Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Quince Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2026-06-30 $31k 1.7k 18.19

More positions owned by BlackRock

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Micron Technology (MU)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for BlackRock

Top funds holding Quince Therapeutics

Tudor Investment Corporation
Ikarian Capital
Millennium Management
Balyasny Asset Management
Susquehanna International
Squadron Capital Management
Shay Capital
Boothbay Fund Management
Jane Street
Vanguard Capital Management
Cormorant Asset Management
UBS Group
Vanguard Fiduciary Trust
BlackRock
Tower Research Capital

View all funds holding Quince Therapeutics